• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Lonza
Manufacturing

Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business

The addition of five manufacturing sites will more than double Lonza’s U.S. footprint and add 1,100 employees to the Swiss CDMO's U.S. roster.
Angus Liu Nov 3, 2026 9:21am
Resource Icon
The direct-to-patient DTP market is full of providers making bold claims But claims are not outcomes To unlock the true p

DTP – Delivering Proof Over Promise

Brought to you by Gifthealth
Holly Robinston Peete and Rodney Peete

Sumitomo's Gemtesa drives home overactive bladder awareness

Nov 2, 2026 4:53pm
FDA

Hansoh, Samsung Bio written up after FDA inspections

Nov 2, 2026 2:56pm
photo of a green light on a stoplight

Inovio wins FDA nod for DNA-based immunotherapy in rare disease

Nov 2, 2026 10:53am
bid

Karyopharm files Chapter 11 ahead of Ayrmid merger

Nov 2, 2026 10:46am
More News

Compass points to unmet need as psychedelic nears market

Nov 2, 2026 10:33am

Fresenius targets €370B originator market with WuXi Bio deal

Nov 2, 2026 9:43am

Sanofi tips Dupixent to reap rewards from Lilly’s Ebglyss ads

Nov 2, 2026 2:27am

Regulatory tracker: Ilumya's expansion; Bayer gets 1st FXIa nod

Oct 30, 2026 3:41pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings